Shares in Acceleron have been grown by the third in the last month, and closed on Friday at almost $168, not far off its 52-week high of $174. Image Phil Taylor ...
Hedge fund Darwin – which has a 3.84% stake in Acceleron – said that a fair value would be at least twice Merck's current offer, adding to earlier resistance from Avoro, which holds 7% of ...